Sources of variability in determining malaria parasite density by microscopy.

PubWeight™: 2.34‹?› | Rank: Top 2%

🔗 View Article (PMC 2500224)

Published in Am J Trop Med Hyg on September 01, 2005

Authors

Wendy Prudhomme O'Meara1, F Ellis McKenzie, Alan J Magill, J Russ Forney, Barnyen Permpanich, Carmen Lucas, Robert A Gasser, Chansuda Wongsrichanalai

Author Affiliations

1: Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA. prudhomw@mail.nih.gov

Articles citing this

A research agenda for malaria eradication: diagnoses and diagnostics. PLoS Med (2011) 5.80

The parasite clearance curve. Malar J (2011) 4.30

Establishing a malaria diagnostics centre of excellence in Kisumu, Kenya. Malar J (2007) 2.33

Working without a blindfold: the critical role of diagnostics in malaria control. Malar J (2008) 2.14

Changing patterns of Plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. Am J Trop Med Hyg (2006) 1.93

Reader technique as a source of variability in determining malaria parasite density by microscopy. Malar J (2006) 1.68

Malaria Diagnosis Using a Mobile Phone Polarized Microscope. Sci Rep (2015) 1.56

Systematic comparison of two methods to measure parasite density from malaria blood smears. Parasitol Res (2006) 1.40

Reliable enumeration of malaria parasites in thick blood films using digital image analysis. Malar J (2009) 1.36

Development of fluorescent Plasmodium falciparum for in vitro growth inhibition assays. Malar J (2010) 1.31

The use of schools for malaria surveillance and programme evaluation in Africa. Malar J (2009) 1.31

Inter-rater reliability of malaria parasite counts and comparison of methods. Malar J (2009) 1.30

Malaria vaccine efficacy: the difficulty of detecting and diagnosing malaria. Malar J (2007) 1.29

Assessing agreement between malaria slide density readings. Malar J (2010) 1.12

New technologies for reporting real-time emergent infections. Parasitology (2012) 1.10

Gametocytemia and fever in human malaria infections. J Parasitol (2007) 1.06

Gametocytemia in Plasmodium vivax and Plasmodium falciparum infections. J Parasitol (2006) 1.02

Fever in patients with mixed-species malaria. Clin Infect Dis (2006) 0.95

Developing standards for malaria microscopy: external competency assessment for malaria microscopists in the Asia-Pacific. Malar J (2012) 0.89

Enhanced understanding of infectious diseases by fusing multiple datasets: a case study on malaria in the Western Brazilian Amazon region. PLoS One (2011) 0.88

Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon. Am J Trop Med Hyg (2013) 0.87

Parasite threshold associated with clinical malaria in areas of different transmission intensities in north eastern Tanzania. BMC Med Res Methodol (2009) 0.85

A quality control program within a clinical trial Consortium for PCR protocols to detect Plasmodium species. J Clin Microbiol (2014) 0.82

Statistical properties of parasite density estimators in malaria. PLoS One (2013) 0.81

Development of new malaria diagnostics: matching performance and need. Malar J (2016) 0.80

Evaluating the effectiveness of IPTi on malaria using routine health information from sentinel health centres in southern Tanzania. Malar J (2011) 0.79

Inter-observer agreement according to malaria parasite density. Malar J (2013) 0.78

Standardization of blood smears prepared in transparent acetate: an alternative method for the microscopic diagnosis of malaria. Malar J (2014) 0.78

Feasibility of flow cytometry for measurements of Plasmodium falciparum parasite burden in studies in areas of malaria endemicity by use of bidimensional assessment of YOYO-1 and autofluorescence. J Clin Microbiol (2011) 0.75

Bayesian hierarchical regression on clearance rates in the presence of "lag" and "tail" phases with an application to malaria parasites. Biometrics (2015) 0.75

Articles cited by this

White blood cell counts and malaria. J Infect Dis (2005) 3.46

Diagnostic disagreement--the lessons learnt from malaria diagnosis in Mpumalanga. S Afr Med J (1997) 3.31

Dependence of malaria detection and species diagnosis by microscopy on parasite density. Am J Trop Med Hyg (2003) 3.07

Reliability of malaria microscopy in epidemiological studies: results of quality control. Trop Med Int Health (2000) 2.90

What is clinical malaria? Finding case definitions for field research in highly endemic areas. Parasitol Today (1994) 2.90

Statistical considerations in the microscopical diagnosis of Malaria, with special reference to the role of cross-checking. Bull World Health Organ (1966) 2.38

Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am J Trop Med Hyg (1997) 2.36

Clinical case definitions for malaria: clinical malaria associated with very low parasite densities in African infants. Trans R Soc Trop Med Hyg (1999) 2.08

Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen. J Clin Microbiol (2003) 2.08

Malaria rapid diagnostic devices: performance characteristics of the ParaSight F device determined in a multisite field study. J Clin Microbiol (2001) 1.90

What does a single determination of malaria parasite density mean? A longitudinal survey in Mali. Trop Med Int Health (2000) 1.78

Malaria diagnosis. Am J Trop Med Hyg (1999) 1.01

Studies on the detection of malaria at primary health centres. Part I. Reliability of parasitological diagnosis by decentralized laboratories. Indian J Malariol (1985) 1.01

Three case definitions of malaria and their effect on diagnosis, treatment and surveillance in Cox's Bazar district, Bangladesh. Bull World Health Organ (2001) 0.95

Articles by these authors

Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature (2002) 12.09

Update on rapid diagnostic testing for malaria. Clin Microbiol Rev (2008) 5.41

Revisiting the basic reproductive number for malaria and its implications for malaria control. PLoS Biol (2007) 5.40

Statics and dynamics of malaria infection in Anopheles mosquitoes. Malar J (2004) 4.65

Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border. Am J Trop Med Hyg (2007) 4.51

Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother (2003) 4.01

Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol (2006) 3.80

Rapid diagnostic testing for malaria. Trop Med Int Health (2003) 3.63

White blood cell counts and malaria. J Infect Dis (2005) 3.46

The risk of a mosquito-borne infection in a heterogeneous environment. PLoS Biol (2004) 3.46

Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol (2006) 3.42

Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia. Malar J (2009) 3.19

In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health (2006) 3.14

Dependence of malaria detection and species diagnosis by microscopy on parasite density. Am J Trop Med Hyg (2003) 3.07

Histidine-rich protein II: a novel approach to malaria drug sensitivity testing. Antimicrob Agents Chemother (2002) 3.01

Emerging rickettsioses of the Thai-Myanmar border. Emerg Infect Dis (2003) 2.91

Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg (2006) 2.86

The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar J (2009) 2.66

A comparison of two rapid field immunochromatographic tests to expert microscopy in the diagnosis of malaria. Acta Trop (2002) 2.39

Ross, macdonald, and a theory for the dynamics and control of mosquito-transmitted pathogens. PLoS Pathog (2012) 2.38

Establishing a malaria diagnostics centre of excellence in Kisumu, Kenya. Malar J (2007) 2.33

An elaborated feeding cycle model for reductions in vectorial capacity of night-biting mosquitoes by insecticide-treated nets. Malar J (2007) 2.33

Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J (2009) 2.33

A simulation model of African Anopheles ecology and population dynamics for the analysis of malaria transmission. Malar J (2004) 2.29

Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J (2004) 2.29

Relationship between exposure, clinical malaria, and age in an area of changing transmission intensity. Am J Trop Med Hyg (2008) 2.29

Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen. J Clin Microbiol (2003) 2.08

Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2006) 2.04

Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2010) 2.04

Hematologic and clinical indices of malaria in a semi-immune population of western Thailand. Am J Trop Med Hyg (2004) 1.99

Origin and evolution of sulfadoxine resistant Plasmodium falciparum. PLoS Pathog (2010) 1.96

Production and validation of durable, high quality standardized malaria microscopy slides for teaching, testing and quality assurance during an era of declining diagnostic proficiency. Malar J (2006) 1.95

The unexpected importance of mosquito oviposition behaviour for malaria: non-productive larval habitats can be sources for malaria transmission. Malar J (2005) 1.93

Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob Agents Chemother (2007) 1.85

Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol (2003) 1.83

Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007. Antimicrob Agents Chemother (2010) 1.76

pfmdr1 genotyping and in vivo mefloquine resistance on the Thai-Myanmar border. Am J Trop Med Hyg (2005) 1.76

Evaluation of diagnostic tests for infectious diseases: general principles. Nat Rev Microbiol (2006) 1.76

Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrob Agents Chemother (2009) 1.74

Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria. PLoS Med (2006) 1.72

Reader technique as a source of variability in determining malaria parasite density by microscopy. Malar J (2006) 1.68

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research. Vaccine (2007) 1.68

Rapid diagnostic devices for malaria: field evaluation of a new prototype immunochromatographic assay for the detection of Plasmodium falciparum and non-falciparum Plasmodium. Am J Trop Med Hyg (2003) 1.57

Unusual plasmodium malariae-like parasites in southeast Asia. J Parasitol (2002) 1.56

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. Vaccine (2007) 1.55

South American Plasmodium falciparum after the malaria eradication era: clonal population expansion and survival of the fittest hybrids. PLoS One (2011) 1.55

Topical paromomycin with or without gentamicin for cutaneous leishmaniasis. N Engl J Med (2013) 1.54

Detection of Ehrlichia spp., Anaplasma spp., Rickettsia spp., and other eubacteria in ticks from the Thai-Myanmar border and Vietnam. J Clin Microbiol (2003) 1.53

Using the entomological inoculation rate to assess the impact of vector control on malaria parasite transmission and elimination. Malar J (2010) 1.49

Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing. Proc Natl Acad Sci U S A (2010) 1.45

Co-infection with malaria and leptospirosis. Am J Trop Med Hyg (2003) 1.43

Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg (2011) 1.43

World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility. Malar J (2007) 1.41

Systematic comparison of two methods to measure parasite density from malaria blood smears. Parasitol Res (2006) 1.40

A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR. Malar J (2004) 1.36

Environmental factors associated with the malaria vectors Anopheles gambiae and Anopheles funestus in Kenya. Malar J (2009) 1.36

Measuring allelic heterogeneity in Plasmodium falciparum by a heteroduplex tracking assay. Am J Trop Med Hyg (2005) 1.35

Drug-Resistant Malaria: The Era of ACT. Curr Infect Dis Rep (2010) 1.33

Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. Am J Trop Med Hyg (2006) 1.29

Impregnated netting slows infestation by Triatoma infestans. Am J Trop Med Hyg (2008) 1.29

Malaria vaccine efficacy: the difficulty of detecting and diagnosing malaria. Malar J (2007) 1.29

Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites. Genome Res (2010) 1.27

Parasite prevalence: a static measure of dynamic infections. Am J Trop Med Hyg (2007) 1.27

Age-structured red blood cell susceptibility and the dynamics of malaria infections. Proc Natl Acad Sci U S A (2004) 1.25

The spatial and temporal patterns of falciparum and vivax malaria in Perú: 1994-2006. Malar J (2009) 1.25

Epidemiology and spatial analysis of malaria in the Northern Peruvian Amazon. Am J Trop Med Hyg (2006) 1.21

Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty. Malar J (2010) 1.20

Multiple genetic origins of histidine-rich protein 2 gene deletion in Plasmodium falciparum parasites from Peru. Sci Rep (2013) 1.20

The promise and potential challenges of intermittent preventive treatment for malaria in infants (IPTi). Malar J (2005) 1.18

Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand. Antimicrob Agents Chemother (2010) 1.18

Nontraumatic deaths during U.S. Armed Forces basic training, 1977-2001. Am J Prev Med (2004) 1.18

Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein. Clin Vaccine Immunol (2012) 1.17

Molecular surveillance for multidrug-resistant Plasmodium falciparum, Cambodia. Emerg Infect Dis (2008) 1.16

Identification of potent chemotypes targeting Leishmania major using a high-throughput, low-stringency, computationally enhanced, small molecule screen. PLoS Negl Trop Dis (2009) 1.14

Plasmodium falciparum: effect of anti-malarial drugs on the production and secretion characteristics of histidine-rich protein II. Exp Parasitol (2003) 1.13

Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010. Southeast Asian J Trop Med Public Health (2013) 1.13

Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia. J Infect Dis (2010) 1.12

An outbreak of Plasmodium falciparum malaria in U.S. Marines deployed to Liberia. Am J Trop Med Hyg (2010) 1.12

Plasmodium vivax isolates from Cambodia and Thailand show high genetic complexity and distinct patterns of P. vivax multidrug resistance gene 1 (pvmdr1) polymorphisms. Am J Trop Med Hyg (2013) 1.09

Importance of protection of antimalarial combination therapies. Lancet (2004) 1.08

Community and facility-level engagement in planning and budgeting for the government health sector--a district perspective from Kenya. Health Policy (2010) 1.07

Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru. Am J Trop Med Hyg (2005) 1.06

Misclassification of drug failure in Plasmodium falciparum clinical trials in southeast Asia. J Infect Dis (2009) 1.05

Nigeria Anopheles vector database: an overview of 100 years' research. PLoS One (2011) 1.05

Host control of malaria infections: constraints on immune and erythropoeitic response kinetics. PLoS Comput Biol (2008) 1.05